Back to results
US 12,642,869 B2Granted
Regulatable adeno-associated virus (AAV) vector
AssigneeGeorg-August-UniversitäT GöTtingen Stiftung öFfentlichen Rechts, UniversitäTsmedizin
InventorSebastian Kügler
Life of this patent
Estimating the term…
Abstract
The present invention relates to regulatable adeno-associated virus (AAV) vectors as well as to their use in gene therapy. It further relates to corresponding nucleic acid molecules, host cells, non-human transgenic animals, pharmaceutical compositions and kits.
Claims19
An adeno-associated virus (AAV) vector comprising
- (i) a first expression cassette comprising a first promoter and a coding sequence for a regulator protein, wherein the first promoter directs expression of the regulator protein, wherein the regulator protein is activated in the presence of an activator molecule, and wherein the regulator protein comprises a GAL4 DNA binding domain, a progesterone receptor ligand binding domain, and the p65 transactivation domain from NF-kappaB, and
- (ii) a second expression cassette directing the expression of comprising a promoter region and a coding sequence for a molecule of interest, wherein the promoter region regulates expression of the molecule of interest, wherein the promoter region comprises one or more GAL4 binding sites and a second promoter, and wherein, and the expression of the molecule of interest is induced by binding of the activated regulator protein to the promoter region, wherein the first expression cassette and the second expression cassette are arranged in a tail-to-head configuration, and wherein the first expression cassette and the second expression cassette are separated by a transcription blocker sequence comprising a transcription pause site and a polyadenylation signal sequence.
An AAV vector construct comprising
- (i) a first expression cassette comprising a first promoter and a coding sequence for a regulator protein, wherein the first promoter directs expression of the regulator protein under the control of a first promoter, wherein the regulator protein is activated in the presence of an activator molecule, and wherein the regulator protein comprises a GAL4 DNA binding domain, a progesterone receptor ligand binding domain, and the p65 transactivation domain from NF-kappaB, and
- (ii) a second expression cassette comprising a promoter region and a multiple cloning site allowing the insertion of a coding sequence for a molecule of interest, wherein the promoter region regulates expression of the molecule of interest following insertion of the coding sequence for the molecule of interest, wherein the promoter region comprises one or more GAL4 binding sites and a second promoter, and wherein the expression of the molecule of interest is induced by binding of the activated regulator protein to the promoter region, wherein the first expression cassette and the second expression cassette are arranged in a tail-to-head configuration, and wherein the first expression cassette and the second expression cassette are separated by a transcription blocker sequence comprising a transcription pause site and a polyadenylation signal sequence.
Dependencies are inferred from the claim text.